InVivoScribe Technologies, L.L.C.
Management Team

Jeffrey E. Miller, Ph.D.
Chief Scientific & Chief Executive Officer
Chairman, InVivoScribe's Board of Directors



James B. Isaacs, Jr
Licensing and Contracts Counsel
Member, InVivoScribe's Board of Directors



Gary R. Clouse
Senior Legal Counsel, Special Projects
Member, InVivoScribe's Board of Directors



Graeme Duncan
Director of Global Marketing



Mitchell Kronenberg, Ph.D.
Chairman, Scientific Advisory Board
Member, InVivoScribe's Board of Directors



Stephen S. Wilson, Ph.D.
Scientific Advisory Board
Member, InVivoScribe's Board of Directors



James C. Weseman
Senior Legal Counsel, Intellectual Property



Donald Huffman
Director of Operations



About Us

InVivoScribe Technologies is a privately-held biotechnology company located in San Diego, California, with a sales and distribution office (InVivoScribe Technologies, SARL) located in La Ciotat, Provence, France.

The company is dedicated to improving the quality of healthcare worldwide by providing high quality, reliable, cutting-edge tools for molecular diagnostics, hematopathology and cDNA synthesis.

The company was founded in 1995 based upon InVivoScribe's patented in vivo cDNA synthesis technologies. These technologies convert unstable cellular messenger RNA into stable complementary DNA within the living cells and tissues - enhancing the quality and reproducibility of cDNA products and eliminating difficulties and bias associated with RNA extraction and in vitro methods for cDNA synthesis.

InVivoScribe provides a comprehensive selection of PCR-based gene rearrangement, chromosome translocation, and gene mutation testing reagents and controls. Customers include many of the world's leading pharmaceutical and biotechnology companies, medical centers, cancer research centers, reference laboratories and molecular testing centers.

Our research and in vitro diagnostic products are used to identify, classify and follow leukemias, lymphomas and other lymphoproliferative disease.

As a contract research organization, InVivoScribe provides tests and services to assist in the development of pharmaceutical agents and devices. We also produce OEM Reagents dedicated for use with specific analytical platforms.

InVivoScribe's gene rearrangement products, and certain of our gene mutation testing products are covered by exclusive-licensed patents. The company is debt-free and has been profitable since the beginning of this decade.


By using this website, you agree to the Terms of Use.
©2009 InVivoScribe Technologies, Inc.